# Progesterone Effect on Individuals Diagnoses With AD and PTSD.

> **NCT02187224** · PHASE2,PHASE3 · COMPLETED · sponsor: **Yale University** · enrollment: 13 (actual)

## Conditions studied

- Alcohol Dependence
- Post-Traumatic Stress Disorder (PTSD)

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Placebo (for Progesterone)

## Key facts

- **NCT ID:** NCT02187224
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2021-09-08
- **Final completion:** 2021-09-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02187224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02187224, "Progesterone Effect on Individuals Diagnoses With AD and PTSD.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02187224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*